Carson Wealth (CWM LLC)
ACHN

Carson Wealth (CWM LLC)’s Achillion Pharmaceuticals ACHN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-75
Closed – – 3440
2018
Q4 		$0 Hold
75
– – ﹤0.01% 2333
2018
Q3 		$0 Hold
75
– – ﹤0.01% 2065
2018
Q2 		$0 Hold
75
– – ﹤0.01% 1817
2018
Q1 		$0 Hold
75
– – ﹤0.01% 1594
2017
Q4 		$0 Hold
75
– – ﹤0.01% 1631
2017
Q3 		$0 Hold
75
– – ﹤0.01% 1603
2017
Q2 		$0 Sell
75
-100
-57% -$402 ﹤0.01% 1357
2017
Q1 		$1K Buy
175
+100
+133% +$415 ﹤0.01% 1136
2016
Q4 		$0 Hold
75
– – ﹤0.01% 1222
2016
Q3 		$1K Buy
+75
New +$638 ﹤0.01% 970

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ACHN Position: Q1 2019 in Review

Carson Wealth (CWM LLC) sold out of Achillion Pharmaceuticals (ACHN) in Q1 2019, closing a stake of 75 shares.

Carson Wealth (CWM LLC) first reported a position in ACHN in Q3 2016 and held it in 10 quarters. The position peaked at $1K in Q1 2017. 110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

  • Carson Wealth (CWM LLC) reported no remaining Achillion Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 75 Achillion Pharmaceuticals shares in Q1 2019.
  • Carson Wealth (CWM LLC) first reported a position in Achillion Pharmaceuticals in Q3 2016 and held it in 10 quarters.
  • Carson Wealth (CWM LLC)'s Achillion Pharmaceuticals position peaked at $1K in Q1 2017.
  • 110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2019, filed 22 Apr 2019.